The Arab Hospital Magazine issue 186

Issue 186 l March 2022 www.thearabhospital.com

l 2022

Publisher Arab Health Media Communication President Simon Chamma chamma @tahmag.com Mirna Khairallah mirna@tahmag.com Simon Semaan Elham Najem Editors May Atallah, Adel Abdel Karim Najib Zein, Dany Khairallah Je ie Chlela je ie@tahmag.com Rania Khalil rania@tahmag.com Wadih Chamma wadih@tahmag.com Elie Yammine elie@tahmag.com Hanna Nehme adverti ing@thearabho pital.com OFFICES T: +961 4 53 40 58 M: +961 3 60 61 00 +357 96 158661 +967 50 2971007

KSA - UAE - OMAN - TURKEY LEBANON - JORDAN - KUWAIT BAHRAIN - QATAR - EGYPT All image from hutter tock© unle provided by client .

All right re erved by the HOSPITALS magazine. No part of thi publication can be reproduced in any form without prior permi ion in writting from the publi her.

l 2022

150

BEST

CHILDREN’S HOSPITALS

2022

l

NEWTOM 7G WIDE.VISION

NEW IMAGING HORIZONS. Featuring a large gantry aperture, the NewTom 7G is the most advanced CBCT device on the market. From in-depth detail to the big picture.

ULTRA-DETAILED MULTI-DIAGNOSTICS Localised analysis over the entire body. Ray2D and 3D imaging up to 90 µm, also with radiocontrast agent. Artifact reduction and movement analysis using CineX and Cine-Scout. The eXtra Functions protocol extends the field of view longitudinally to analyse anatomical structures such as the spine and limbs.

TECHNOLOGICAL EXCELLENCE High power generator (120 kV – 20kW). High-sensitivity 3D panel and innovative algorithms for volumetric reconstruction. 77 cm gantry aperture.

ERGONOMICS AND PRACTICALITY Fully motor-powered table and 10” touch-screens, front and rear.

Optimised examination flow thanks to certified NNT software with processing, sharing and RIS/PACS connectivity functions.

MAXIMISING PATIENT CARE The patient lies comfortably on the table and X-ray doses are always proportioned to the patient’s build and the examination type thanks to SafeBeamtm technology.

l 2022

www.newtom.it

Issue 186 l March 2022 www.thearabhospital.com

August March June 2021 2022

186 177 179

-36-

20 8 22 10 28 2022

12 30 14

GC MARK

32

16 2022

34

2022

18

l

Multicare X Discover new ICU solution designed by nurses for nurses

67%

Decrease in force needed to turn the patient with lateral tilt

@LINETMEA l 2022

@LINETMEA

@LINET

-66-

-52-

92

96

94 BD

70

40

BD

42

98

54 56

15000

30

46

UChicago Medicine

50

36 44

60 62 66

72 82

2022

l

l 2022

2022

l

‫ّ‬ ‫ﺗﺘﻮﻗﻔﻮا ﻋﻦ اﻟﺘﻌ ّﻠﻢ‬ ‫ﻻ‬ ‫ّ‬ ‫ﺗﺘﻮﻗﻔﻮا ﻋﻦ ﺗﻄﻮﻳﺮ اﻟﺬات‬ ‫ﻻ‬ ‫إﺗﺎﺣﺔ ﻓﺮص رﻓﻴﻌﺔ اﻟﻤﺴﺘﻮى ‪B‬ﺻﺤﺎب اﻟﻤﻬﻦ اﻟﺼﺤﻴﺔ ﺗﺴﺘﻨﺪ إﻟﻰ أﺣﺪث اﻟﺘﻄﻮرات وا‪-‬ﻧﺠﺎزات اﻟﻌﻠﻤﻴﺔ‬ ‫اﻟﻤﻘﺪﻣﺔ ﻟﻠﻤﺮﺿﻰ‪.‬‬ ‫واﻟﻄﺒﻴﺔ‪ ،‬ﺑﻬﺪف إﺛﺮاء اﻟﻜﻔﺎءات وﺗﻌﺰﻳﺰ ا‪B‬داء واﻟﻨﻬﻮض ﺑﻤﻌﺎﻳﻴﺮ اﻟﺮﻋﺎﻳﺔ اﻟﺼﺤﻴﺔ‬ ‫ّ‬ ‫ﻟﻤﺰﻳﺪ ﻣﻦ اﻟﻤﻌﻠﻮﻣﺎت‪qatar-weill.cornell.edu/continuing-professional-development/ :‬‬

‫‪ l 2022‬‬

260,000

OMIM(

700

2021

300

2022

l

Master Exécutif en Management de la Santé INSCRIPTIONS EN COURS

Un programme qui vous permet de faire face aux nouveaux défis de l’environnement de la santé au Liban et au Moyen-Orient.

Le Master Exécutif en Management de la Santé de l’ESA : le programme idéal pour aider les auditeurs à maîtriser le langage et les outils du management des milieux de la Santé.

Son objectif est de comprendre l’évolution des contraintes pesant sur les établissements de santé, notamment en matière de : • démarche qualité (procédure de certification), • sécurité (des actes, de la prise en charge), • gestion des risques (locaux, patients, personnels), • information du patient et droit hospitalier, • optimisation de la performance, • gouvernance et pôles.

Programme intégralement animé par les meilleurs experts internationaux du secteur de la santé.

2 DIPLÔMES : • Le MEMS « Master Exécutif en Management de la Santé » de l’ESA • L’AMES « Analyse et Management des Etablissements de Santé » de l’Université de Paris, diplôme d’État.

Formation en 16 mois

En partenariat avec

BBA

289 rue Clemenceau, Beyrouth, Liban, T +961 1 373 373 ext.1126 E masters@esa.edu.lb

l 2022

LEADERS DE DEMAIN www.esa.edu.lb

3

5

2022

l

l 2022

1000

2016 2015 2002

2020

2010

11 20

2022

l

Award-winning care meets humankindness.

Medical breakthroughs have continued to help people live healthier lives, and we’re honored to be recognized for them.

With our new rankings by U.S. News & World Report, we celebrate these advancements and the power of humankindness to provide healing for our communities in the best way.

Learn more at stlukeshealth.org./bslmcinternational

l 2022

2022

27 2022

2022

27

2022

l

l 2022

2022

l

l 2022

1AsterApp 2022

30

25

2022

17 2025

2022

l

NATIONWIDE CHILDREN’S HOSPITAL WORLD-CLASS PROGRAMS. TRAILBLAZING RESEARCH. PERSONALIZED CARE. Columbus, Ohio, may feel like a world away, but our faculty, researchers and facility have earned international reputations for expertise in rare and complex conditions. Our Cardiovascular team is leading groundbreaking development of a biodegradable tissue-engineered vascular graft for children with congenital heart defects. Our multidisciplinary Center for Colorectal and Pelvic Reconstruction excels in advanced care for even the rarest congenital disorders, motility issues, fecal incontinence concerns and more, for patients in more than 60 countries. And the powerhouse team at the helm of our Neurosurgery and Neuro-Oncology programs excels in both leadership and collaboration in multinational cancer research. When you’re here, you are the center of our attention. Come to Nationwide Children’s —nothing but the best in care, in an accessible, cosmopolitan city.

Reach out to our Global Patient Services team to find out why we should be your new global destination for complex care.

Learn more, refer a patient or plan a trip: NationwideChildrens.org/Global-Patient-Services GlobalPatientServices@NationwideChildrens.org +1 614 362 9127 Nationwide Children’s Hospital, Columbus, Ohio – USA

l 2022 W295713

AMERICA’S SECOND

LARGEST CHILDREN’S HOSPITAL

* Based on CHA survey of utilization and financial indicators

17 5

2017

2018

.

2022

l

Product Fact Sheet

CyStain VitalCount TM

Fast, safe, sensitive: Control your production the easy way

Product picture

Sysmex Partec GmbH Arndtstraße 11 a-b 02826 Görlitz Germany www.sysmex-partec.com Sysmex Partec is an ISO 9001:2015 and EN ISO 13485:2016 certified company.

Product name CyStainTM VitalCount

Manufacturer information CyStain VitalCount is manufactured by Sysmex Partec GmbH.

Summary CyStain VitalCount is a microbial detection kit for the unspecific detection and quantification of vital microorganisms, yeast and bacteria, in fruit juice, including clear fruit juices, fruit juices with fruit pulp and highviscosity fruit juices. The kit involves manual or automated sample preparation by pipetting robots in a 96-well format.

Juice samples are automatically analysed and results are automatically reported by the CyFlow™ Cube 6 V2m analyser and the CyFlow™ Robby 6 Autoloading Station.

Product Fact Sheet CyStain VitalCount

Productivity values The CyStain VitalCount Kit is an automated, cost-effective and rapid alternative to conventional plate counts. The enumeration of total viable microorganisms allows to assess the microbial burden during in-process control and final product control of any type of fruit juice. The objective and automated read-out of the results allows clear release decision with confidence in routine quality control during juice production.

Specifications Features

Description

Technology

Vital cell stain / Flow cytometry

Sample type

Fruit juice

Species type

Living bacteria and yeast cells

Limit of detection (LoD)

At least < 1000 cells/mL

Limit of blank (LoB)

At least < 500 cells/mL

Sensitivity of the method

1 organism/bottle for bacteria and yeast (after pre-incubation)

Decrease inventory / warehouse costs

Number of tests

480

Reduce human errors due to the automate procedure

Shelf-life

12 months

In-use stability

2 months

Simplified automated operation dedicated to this application

Storage temperature

2 - 8 °C

Format

96-well plate

Objective clear-cut decision due to standardised data reporting

Sample preparation time ~ 80 min for 96 samples

Key features in industrial testing Speed up product release

Highest sensitivity: 1 organism / bottle (pre-incubation necessary)

Ordering information Reagent Article number

Item

05-5029

CyStain VitalCount

Consumables and Instruments Article number

Item

04-2026

96 Well Filter Plates

04-2025

96 Well Receiver Plates

CY-S-3061R-V2m

CyFlow Cube 6 V2m

CY-S-3083-V2m

CyFlow Robby V2m Autoloading Station

Throughput (analysis time)

< 180 min 96 samples

Carry-Over

< 0.1 %

l 2022

2022

l

l 2022

.2022

2022

2021

2022

l

l 2022

2022

2022

l

RANKED AMONGST TOP 100 WORLDWIDE HIGHEST RANKED HOSPITAL IN THE MIDDLE EAST ONLY HOSPITAL RANKED IN LEBANON

l 2022

GC MARK

GC Mark

CDC

ISO(

GC MARK

OECD

GC MARK

DQS GC MARK

DQS

2022

l

l 2022

2022

l

l 2022

2022

l

‫ﻣـﺮﻛـﺰ ا@ﻫـﻠـﻲ ﻟﻠـﻘـﻠـﺐ‬

‫ﻣﻦ اﻟﻘﻠﺐ‪ ،‬ﻓﻘﻂ ﻛﻦ ﺳﻌﻴﺪ!‪..‬‬

‫أﺟﺮى اﻟﻤﺴﺘﺸﻔﻰ ا@ﻫﻠﻲ ﻋﺪد ﻣﻦ اﻟﻌﻤﻠﻴﺎت اﻟﻨﺎﺟﺤﺔ ﻟﻠﻘﻠﺐ اﻟﻤﻔﺘﻮح‪.‬‬ ‫ﺟﺮاﺣﺔ اﻟﻘﻠﺐ واﻟﺼﺪر ﻫﻲ إﺟﺮاء ﺟﺮاﺣﻲ ﻟﻠﻘﻠﺐ واﻻوﻋﻴﺔ اﻟﺪﻣﻮﻳﺔ ﻫﻲ ﻋﺒﺎرة ﻋﻦ ﻣﺠﻤﻮﻋﺔ ﻣﻦ اﻟﺘﺪﺧﻼت‬ ‫اﻟﺠﺮاﺣﻴﺔ اﻟﺘﻰ ﺗﻬﺪف إﻟﻰ إﺻﻼح ﻣﺸﺎﻛﻞ ﻓﻲ اﻟﻘﻠﺐ )اﻟﺼﻤﺎﻣﺎت‪ ،‬واﻟﺸﺮاﻳﻴﻦ اﻟﺘﺎﺟﻴﺔ‪ ،‬وﻋﻀﻠﺔ اﻟﻘﻠﺐ(‪.‬‬ ‫ﻛﻤﺎ ﻳﺘﻢ إﺻﻼح ا‪4‬وﻋﻴﺔ اﻟﺪﻣﻮﻳﺔ)اﺻﺎﺑﺎت اﻟﺸﺮاﻳﻴﻦ و اﻻوردة(‪.‬‬ ‫• ﻋﻤﻠﻴﺎت اﻟﺘﺠﺴﻴﺮ اﻟﺘﺎﺟﻲ‬ ‫• ﻋﻤﻠﻴﺎت ﺗﻐﻴﻴﺮ و اﺻﻼح اﻟﺼﻤﺎﻣﺎت‬ ‫• ﻋﻤﻠﻴﺎت اﻟﺸﺮﻳﺎن ا‪:‬ﺑﻬﺮي‬ ‫• ﺟﺮاﺣﺔ اﻟﺘﺎﻣﻮر‬

‫ﻟﻤﺰﻳﺪ ﻣﻦ اﻟﻤﻌﻠﻮﻣﺎت‬ ‫ﻳﺮﺟﻰ ا‪:‬ﺗﺼﺎل ﻋﻠﻰ ا‪4‬رﻗﺎم اﻟﺘﺎﻟﻴﺔ ‪:‬‬

‫‪ ٤٤٨٩٨٠٠٠‬أو ‪٤٤٨٩٨٨٨٨‬‬ ‫رﻗﻢ اﻻﻋﻼن ‪:‬‬

‫‪ l 2022‬‬

ANGIOTENSIN II

Beta blocker

ACE inhibitors

2022

l

BD

BD

BD

Point of Care POC

HIV

l 2022

BD

BD

BD

BD

BD

Center for Safety and

Clinical Excellence

2022

l

BD

l 2022

BD

BD

BD

BD

2022

l

l 2022

29.5 25 39.5 30

1 2 3

25

BMI

2022

l

l 2022

•

•

•

•

•

•

2022

l

2002

7

2016

l 2022

600

15000

30

100 30

1 200

×2

2022

l

•

100

• US News & World

Report

•

•

EVLP

•

•

•

l 2022

200

150

•

• •

HIPEC •

1927 10

1927

633 3000

200

1200

12

2022

l

BEST

CHILDREN’S HOSPITALS •

•

•

•

•

50

• • • •

•

•

•

•

• •

5000

• •

•

• •

600

l 2022

•

• • •

3

2022

SRTR

300

2000

•

•

• 50

50

• •

SRTR

• •

1000

•

5 1 2

2022

l

l 2022

2022

l

70

2012

15

Next Generation

FDA

LUMAKRAS

l 2022

70

70

2022

l

l 2022

• • • • •

2022

l

BERI BERI

12

MALNUTRITION

l 2022

8

5

12

770

2022

l

l 2022

2022

l

l 2022

2022

l

l 2022

15

30

5

2022

l

•

•

•

•

•

l 2022

2022

l

•

• • CT

MRI

•

•

90

”.

•

•

l 2022

•

• • • • • • • •

• • • • • • •

2022

l

2030

2023

2018-

l 2022

2022

25

2022

l

2022 2022

5000

2022

2022 5000

2022

2022

2022

2022 2022 2022 2022

l 2022

2010

2022

2022

2022

FIFA

2022

2022

FIFA

2021 2022 2022

FIFA

FIFA

2022

2022

2022

FIFA

l

GPW 13(

GAVI

10

2021

500

50

l 2022

10

87

2022

l

2022

FIFA

)Tdap

2021

Tdap

10

l 2022

5

.2022

19

2022

l

l 2022

2022

2022

2024 2022

2022

l

Radiopharmaceutical Lab

3 BETA

120

2021

3

3

2016

7

PEM

l 2022

PET -CT

80%

25 80

3D PEM

2022

l

13

2011

27

2021

120

l 2022

10

2022

l

19

50

19

2022

700

l 2022

6

180

2022

l

l 2022

12 2021

2022

l

Bacterial count in routine quality control

CyStain™ BacCount

Quantify bacteria in minutes instead of days

l 2022

17 6

20

6

10

7

2022

l

•

3

• •

•

l 2022

2022

l

l 2022

30

2022

l

l 2022

FIT

40

95%

2022

l

l 2022

•

• • • •

•

•

•

•

•

2022

l

2022

l